Dr John Banja joins us to discuss the promises and perils of artificial intelligence in health care applications, including potential “megarisks” posed by AI tools themselves.
Force feeding, unnecessary x-rays, misusing health information, and discharging unstable patients are classic dual-loyalty dilemmas reminiscent of the Holocaust.
Streamlining US health care business has raised unique privacy concerns. Bills and explanations of benefits contain protected health information that could be disclosed to someone other than the patient.
Mary Anderlik Majumder, JD, PhD and Christi J. Guerrini, JD
Amendments to the Common Rule and Health Insurance Portability and Accountability Act (HIPAA) raise questions about broad consent and sale of health data.
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.